FindMyKOL

Andrew Hantel, MD

Enriched profile

Assistant Professor of Medicine, Harvard Medical School · Dana-Farber Cancer Institute

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyHematology / OncologyFocusEthics in Clinical Research+4
Active KOLFindMyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2023–2025NIH funding2022–2026

Andrew Hantel is Assistant Professor of Medicine, Harvard Medical School at Dana-Farber Cancer Institute. OpenAlex indexes 111 publications with 1,780 citations (h-index 19); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 25 Oct 2026

Overview

Updated 2 Nov 2026

Andrew Hantel, M.D., is Assistant Professor of Medicine, Harvard Medical School at Dana-Farber Cancer Institute. The public record shows 111 publications with 1,780 citations (h-index 19), centered on Ethics in Clinical Research, Acute Myeloid Leukemia Research, Statistical Methods in Clinical Trials. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (2022–2026).

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Ethics in Clinical Research
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 2 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Leukemia (AML/ALL/CML/CLL)3 trialsHematologic Neoplasms1 trialBreast Cancer1 trialMultiple Myeloma1 trial

Research focus

OpenAlex concept fingerprint
Ethics in Clinical ResearchAcute Myeloid Leukemia ResearchStatistical Methods in Clinical TrialsEthics and bioethics in healthcarePharmaceutical Economics and Policy

Drugs & molecules

across trials, industry payments and publications
Venclextageneric · VenetoclaxClinical trials—Industry payments8Publications—Rylazegeneric · AsparaginaseClinical trials—Industry payments2Publications—Calquencegeneric · AcalabrutinibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments8Dana-Farber Cancer InstituteClinical trials3Industry payments—Jazz Pharmaceuticals Inc.Clinical trials—Industry payments3Andrew Hantel, MDClinical trials1Industry payments—AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Celgene CorporationClinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Genentech, Inc.Clinical trials—Industry payments1GlaxoSmithKline, LLC.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
111publications

Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.

1,780citations

Total citations across indexed works.

19h-index

Hirsch index (OpenAlex). i10-index 33.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
7companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2022–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 2 Nov 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 2 Nov 2026

7 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

All 9 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 2 Nov 2026

1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:

All 5 award records: search, sort and filter.Explore →

Congress activity

Updated 2 Nov 2026

31 congress contributions (2015–2026) across ASCO, ASH per OpenAlex. The most recent:

All 31 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 2 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 22 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Article795 citations2016
    doi.org ↗
  2. 02
    Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome
    Article96 citations2011
    doi.org ↗
  3. 03
    Validation of a financial toxicity (FT) grading system.
    Conference abstract69 citations2017
    doi.org ↗
  4. 04
    Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
    Article65 citations2018
    doi.org ↗
  5. 05
    Perspectives of Oncologists on the Ethical Implications of Using Artificial Intelligence for Cancer Care
    Article58 citations2024
    doi.org ↗
All 111 cited works: search, sort and filter.Explore →

Network

Updated 2 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Gregory Alan Abel55Daniel J. DeAngelo18Thomas P. Walsh17Christopher S. Lathan17Marlise Rachael Luskin12Richard Maury Stone11Mark A. Siegler10Wendy Stock10Jonathan Michael Marron9Lauren E. Merz8Stephen P. Hibbs8Blasé N. Polite8Fay J. Hlubocky7Ann‐Kathrin Eisfeld7Robert Michael Daly6Hajime Uno6Yating Wang6Kristen Wroblewski5Colin Cernik5Emily Senay5Anna C. Revette5Richard A. Larson5Angel M. Cronin5John C. Byrd4Christopher K. Daugherty4Kenneth L. Kehl4Robert J. Soiffer4Jesse J. Plascak4Geoffrey L. Uy4Selina Lai-ming Chow4Yating Wang4Jeffrey M. Peppercorn3Monica Malec3Jane E. Churpek3Michael Todd Huber3Katie E. Lichter3Electra D. Paskett3Irum Khan3Anand Ashwin Patel3Eliezer M. Van Allen3

Online presence

Updated 2 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/andrew-hantel-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    bioethics.hms.harvard.edu/faculty-staff/andrew-hantel

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bioethics.hms.harvard.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 2 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Member

    HMS Center for Bioethics

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bioethics.hms.harvard.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.